FDA Is Rewriting the Premarket Rulebook. Cigar Makers Should Pay Attention.
FDA plans to replace the 2021 rule that governs premarket tobacco applications. The coverage has been about vapes and pouches, but the same rule holds the federal premium cigar definition, the grandfather recordkeeping requirements and the only route to market for a cigar with no predicate.
- On September 28, 2026, FDA said it intends to write a new rule to replace the 2021 PMTA framework. It published no proposal, no timetable and no list of affected products. Current rules stay in force until a new one is final.
- The announcement followed a lawsuit by Altria's Helix and NJOY subsidiaries attacking how FDA starts the 180-day review clock. On October 8, the court in Lubbock stayed the case while FDA writes.
- The 2021 rule is not just a vape rule. Part 1114 is where the federal premium cigar definition is codified, and the same rule created the records manufacturers must keep to prove a product was on the market on February 15, 2007.
- Flavored cigars, cigarillos, machine-made cigars and handmade cigars that miss any of the eight premium elements remain inside FDA's premarket system, and a cigar with no predicate can reach market only through a PMTA.
- Cigar companies should audit their grandfather files, re-check each product against the premium definition and plan to comment when FDA publishes a proposed rule.